@article{711426b8e5544d0ba4ee706d3f104eb3,
title = "Editorial: Translational research for better diagnosis and treatment of endometrial cancer",
keywords = "biomarkers, endometrial cancer, gynaecology, metabolomics, omics, proteomics",
author = "Andrea Romano and Andrzej Semczuk and Janina Tokarz and Ri{\v z}ner, \{Tea Lani{\v s}nik\}",
note = "Funding Information: Currently, both these aspects are not optimal. An invasive endometrial histology is the gold standard for diagnosis, and there are no valid non-invasive methods; also, patient stratification is based on histopathology and surgical findings. To tackle these limitations and to develop non-invasive diagnostic/prognostic tools, the BioEndoCar project was launched in 2018 (funded by EU framework programme Horizon2020). Six European partners and five collaborating centres joined forces to prospectively collect blood specimens from patients and controls, to perform metabolomics and proteomics analyses in plasma samples in search for minimally invasive diagnostic and prognostic biomarkers, and to model the data for the development of prediction algorithms. The BioEndoCar project concluded with a two-day international symposium that was held in Portoro{\v z} (Slovenia, March 2022) focussing on state-of-the-art omics technologies, biobanking, translational research and clinical management in the context of EC. Funding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by project J3-2535 from the Slovenian Research Agency to TLR.",
year = "2023",
month = oct,
day = "19",
doi = "10.3389/fonc.2023.1305140",
language = "English",
volume = "13",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media SA",
number = "1",
}